Skip to main content
. 2020 Jul 27;13:7213–7227. doi: 10.2147/OTT.S246471

Figure 7.

Figure 7

miR-3609 enhanced the in vivo antitumor effects of sorafenib in nude mice. MHCC97-H cells transfected with miR-3609 were injected subcutaneously into nude mice to form tumor tissues. Mice received sorafenib treatment via oral administration. After treatment, the mice were harvested, and the tumor tissues collected. Images of tumor tissues are shown (A) and the inhibitory rates calculated by tumor volumes (B) or tumor weights (C) are indicated; *P < 0.05.